金山科研平台代理微信：jinshanbioKing Bio-Medical代理，King Bio-Medical上海代理，King Bio-Medical北京代理，King Bio-Medical 总代理，King Bio-Medical一级代理，King Bio-Medical国内代理金山科研平台King Bio-Medical专业代理，具体产品信息欢迎咨询微信：jinshanbio

King Bio-Medical代理，King Bio-Medical上海代理，King Bio-Medical北京代理，King Bio-Medical 总代理，King Bio-Medical一级代理，King Bio-Medical国内代理金山科研平台King Bio-Medical专业代理，具体产品信息欢迎咨询微信：jinshanbio：

Congenital Factor II Deficient Plasma

Factor II Deficient plasma is drawn from a human donor with a congenital deficiency.

· Human plasma from donor with congenital FII Deficiency

· Substrate quality

· FII Activity printed on each vial

· No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

Congenital Factor V Deficient Plasma

· Human plasma from donor with congenital FV Deficiency

· Substrate quality

· <1% FV Activity by one stage clotting assay

· No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

Congenital Factor VII Deficient Plasma

Factor VII Deficient plasma is drawn from a human donor with a congenital deficiency.

· Human plasma from donor with congenital FVII Deficiency

· Substrate quality

· <1% FVII Activity by one stage clotting assay

· No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

Congenital Factor VIII Deficient Plasma

Factor VIII Deficient plasma is drawn from a human donor with a congenital deficiency.

· Human plasma from donor with congenital FVIII Deficiency

· Substrate quality

· <1% FVIIIActivity by one stage clotting assay

· No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

Congenital Factor IX Deficient Plasma

Factor IX Deficient plasma is drawn from a human donor with a congenital deficiency.

· Human plasma from donor with congenital FIX Deficiency

· Substrate quality

· <1% IX Activity by one stage clotting assay

· No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

金山科研平台：杨建辉：办公：*8006: :http://www.qfbio.com/地址：上海市浦东新区绣川路561号1102室